AstraZeneca PLC (ZEGA) — Cash Flow Quality Index
AstraZeneca PLC (ZEGA) has a Cash Flow Quality Index of 2.03x as of September 2025. Operating cash flow of €5.13 Billion exceeds net income of €2.53 Billion, indicating high earnings quality where cash backs reported profits. Explore ZEGA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
AstraZeneca PLC Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for AstraZeneca PLC across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of AstraZeneca PLC.
Annual Cash Flow Quality Index for AstraZeneca PLC (2014–2024)
Year-by-year earnings quality comparison for AstraZeneca PLC.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.69x | €11.86 Billion | €7.04 Billion | ▼ -3.0% |
| 2023 | 1.74x | €10.36 Billion | €5.96 Billion | ▼ -41.7% |
| 2022 | 2.98x | €9.81 Billion | €3.29 Billion | ▼ -94.4% |
| 2021 | 53.24x | €5.96 Billion | €112.00 Million | ▲ +3445.7% |
| 2020 | 1.50x | €4.80 Billion | €3.20 Billion | ▼ -32.5% |
| 2019 | 2.22x | €2.97 Billion | €1.33 Billion | ▲ +83.1% |
| 2018 | 1.21x | €2.62 Billion | €2.15 Billion | ▲ +1.9% |
| 2017 | 1.19x | €3.58 Billion | €3.00 Billion | ▲ +0.6% |
| 2016 | 1.18x | €4.14 Billion | €3.50 Billion | ▲ +0.7% |
| 2015 | 1.18x | €3.32 Billion | €2.83 Billion | ▼ -79.4% |
| 2014 | 5.72x | €7.06 Billion | €1.23 Billion | — |